Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11796391 | 0.81 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL28542540 | 0.80 | TSHR (0.32) | TSHR | |
| SCHEMBL9009391 | 0.79 | TSHR (0.42) | TSHR | |
| SCHEMBL9009302 | 0.79 | TSHR (0.42) | TSHR | |
| SCHEMBL7942723 | 0.76 | TSHR (0.41) | TSHR | |
| SCHEMBL10625732 | 0.75 | MAPK1 (0.40) | TSHRMAPK1 | |
| SCHEMBL267594 | 0.75 | PRKCA (0.34) | TSHR | |
| SCHEMBL246513 | 0.73 | TSHR (0.41) | TSHR | |
| SCHEMBL19546012 | 0.73 | PRKCA (0.33) | TSHR | |
| SCHEMBL14775448 | 0.73 | TSHR (0.32) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112390909-B | preparation method and application of pH/salt double-sensitive ether-based functionalized polyion liquid gel | 西安工程大学 | 2022-09-02 | — | — | CN | claimed |
| CN-112473396-B | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2022-06-24 | — | — | CN | claimed |
| CN-112473396-A | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2021-03-12 | — | — | CN | claimed |
| CN-112390909-A | preparation method and application of pH/salt double-sensitive ether-based functionalized polyion liquid gel | 西安工程大学 | 2021-02-23 | — | — | CN | claimed |
| EP-4736988-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | AGC INC. (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4736989-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | AGC INC. (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260115649-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | AGC Inc. (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20260115646-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | AGC Inc. (JP) | 2026-04-30 | — | — | US | disclosed |
| CN-112390909-B | preparation method and application of pH/salt double-sensitive ether-based functionalized polyion liquid gel | 西安工程大学 | 2022-09-02 | — | — | CN | disclosed |
| CN-112473396-B | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-112473396-A | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2021-03-12 | — | — | CN | disclosed |
| CN-112390909-A | preparation method and application of pH/salt double-sensitive ether-based functionalized polyion liquid gel | 西安工程大学 | 2021-02-23 | — | — | CN | disclosed |
| US-6441000-B1 | DISEASES MEDIATED BY OPIATE RECEPTORS | PFIZER INC | 2002-08-27 | — | — | US | disclosed |
| EP-1140896-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | Takeda Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-6235771-B1 | AIDS THERPAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| EP-1055668-A1 | New 4-arylpiperidine derivatives for the treatment of pruritus | PFIZER INC. (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-2000037455-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-06-29 | — | — | WO | disclosed |
| US-5583227-A | INHIBIT SECRETION OF GASTRIC ACID | MOCHIDA PHARMACEUTICAL CO. LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| EP-0685468-A1 | Pyrazine and quinoxaline derivatives and their use as anti-ulcer agents | Mochida Pharmaceutical Co., Ltd. (JP) | 1995-12-06 | — | — | EP | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115646-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | CA7, CA3, CA12 | TSHR 4085/4885MAPK1 3393/4885 |
| US-20260115649-A1 | ACIDIC GAS-ABSORBING LIQUID AND ACIDIC GAS REDUCTION METHOD | CA7, CA9, CA12 | TSHR 4262/4885MAPK1 3244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.